News for 'drug development'

Naxalism with guns or pens must be uprooted: Modi tells state home ministers

Naxalism with guns or pens must be uprooted: Modi tells state home ministers

Rediff.com28 Oct 2022

Prime Minister Narendra Modi on Friday mooted the idea of "One Nation, One Uniform" for the police, saying it is just a suggestion for consideration and he is not trying to impose it on the states.

Zydus Cadila seeks nod for its COVID vaccine for 12 years, above

Zydus Cadila seeks nod for its COVID vaccine for 12 years, above

Rediff.com1 Jul 2021

Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture 10-12 crore doses annually.

Toxins in cough syrups, other drugs due to plastic bottling

Toxins in cough syrups, other drugs due to plastic bottling

Rediff.com1 Jun 2016

Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.

Aryan Episode Won't Affect Brand SRK

Aryan Episode Won't Affect Brand SRK

Rediff.com17 Nov 2021

SRK's persona and brand power has been built over nearly 30 years of public acclaim and love. Brands perhaps believe that his troubles are transitory and that as a human brand he has long legs capable of striding over controversies, explains ad guru Sandeep Goyal.

'Cyber attackers are 10 steps ahead'

'Cyber attackers are 10 steps ahead'

Rediff.com4 Apr 2023

'Hacking of an ID or an account will have the same impact on a user in a city and one in a small town.' 'Security is like a railroad, you create it to last for every customer.'

'COVID-19 is deadly in 0.1 per cent people'

'COVID-19 is deadly in 0.1 per cent people'

Rediff.com20 Oct 2020

'Some of the longer-term implications of COVID-19 are not related to the virus itself.' 'They are actually related to immune responses from the virus.'

'Decisive turning point': PM hails approval to vaccines

'Decisive turning point': PM hails approval to vaccines

Rediff.com3 Jan 2021

In a series of tweets after the Drugs Controller General of India (DCGI) approved Oxford's vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency use, Modi said it will make every Indian proud that both the vaccines are made in India.

COVID-19 vaccines don't belong to any political party: Omar Abdullah

COVID-19 vaccines don't belong to any political party: Omar Abdullah

Rediff.com2 Jan 2021

The more people get vaccinated, the better it will be for the country and the economy, the National Conference vice president said.

ICMR gets civil aviation ministry's conditional nod to use drones for vaccine delivery

ICMR gets civil aviation ministry's conditional nod to use drones for vaccine delivery

Rediff.com13 Sep 2021

The ICMR has been permitted to use drones up to a height of 3,000 metre to deliver vaccines, the ministry's statement added.

Schwarz stops Ranbaxy drug

Schwarz stops Ranbaxy drug

Rediff.com8 Nov 2004

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

'Why the fuss over hydroxychloroquine?'

'Why the fuss over hydroxychloroquine?'

Rediff.com7 Apr 2020

'India is a pharma dada. We can manufacture enough for our people and for the world.'

Serum Institute gets DGCI nod to manufacture Sputnik V in India

Serum Institute gets DGCI nod to manufacture Sputnik V in India

Rediff.com4 Jun 2021

The Drugs Controller General of India (DCGI) has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said.

Oxford vaccine may be first to get nod for emergency use in India

Oxford vaccine may be first to get nod for emergency use in India

Rediff.com26 Dec 2020

Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on COVID-19 at the Central Drugs Standard Control Organisation (CDSCO) will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here, official sources said.

Shortage of key chemical from US hits Covaxin ramp-up plans

Shortage of key chemical from US hits Covaxin ramp-up plans

Rediff.com22 Apr 2021

'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Semenya offered to show body to IAAF officials for proof

Semenya offered to show body to IAAF officials for proof

Rediff.com25 May 2022

Double Olympic 800 metres champion Caster Semenya offered to show her vagina to athletics officials when she was 18 to prove she was female,

India to start world's biggest vaccination drive: PM

India to start world's biggest vaccination drive: PM

Rediff.com4 Jan 2021

Lauding the scientists and technicians for the 'Made in India' vaccines, he said the country is proud of them.

Bharat Biotech's Covid vaccine gets nod for Phase 3 trial

Bharat Biotech's Covid vaccine gets nod for Phase 3 trial

Rediff.com23 Oct 2020

The phase 3 clinical trial will cover around 28,500 subjects, aged 18 years and above, and it will be conducted in 21 sites across ten states, including Delhi, Mumbai, Patna and Lucknow.

Amid row, ICMR defends COVID-19 vaccine deadline

Amid row, ICMR defends COVID-19 vaccine deadline

Rediff.com4 Jul 2020

ICMR says it is following all globally accepted norms to fast-track vaccine and wants to 'cut red tape'.

Hydroxychloroquine can be fatal: Experts

Hydroxychloroquine can be fatal: Experts

Rediff.com6 May 2020

As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.

J&J in talks with India for study of single-dose vaccine

J&J in talks with India for study of single-dose vaccine

Rediff.com9 Apr 2021

India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.

How Covid took devastating turn in 2021

How Covid took devastating turn in 2021

Rediff.com29 Dec 2021

A second wave of Covid driven by the Delta variant engulfed the country in May-June bringing the health system to its knees and leaving people gasping for help.

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

'Safety, efficacy main concerns with Russia's COVID-19 vaccine'

Rediff.com17 Aug 2020

Nobel laureate Peter Doherty says his 'big worry' is there could be refusals for other vaccines if doubts over its safety turn out to be true.

'50 to 60 crore across India would be infected'

'50 to 60 crore across India would be infected'

Rediff.com20 May 2021

'At least half the population in UP has been infected.'

Manish Tewari slams 'chaos, anarchy' in Cong, Sidhu says focus on real issues

Manish Tewari slams 'chaos, anarchy' in Cong, Sidhu says focus on real issues

Rediff.com24 Oct 2021

Punjab Congress chief Navjot Singh Sidhu on Sunday said the state must concentrate on real issues that concern every Punjabi even as MP Manish Tewari said he never saw "such chaos and anarchy" being played out in the party's state unit.

Novartis buys GSK's cancer drugs for $16 bn in three-part deal

Novartis buys GSK's cancer drugs for $16 bn in three-part deal

Rediff.com22 Apr 2014

In separate statements, the two companies said they will combine Novartis' over-the-counter division with GSK's consumer business, creating a new world-leading consumer healthcare business with $10 billion in annual sales.

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Rediff.com24 Jun 2020

Ramdev's herbal medicine company Patanjali Ayurved has launched 'Coronil tablet and Swasari vati' medicines claiming they can cure the highly contagious disease within seven days.

PM to meet COVID-19 vaccine manufacturers on today

PM to meet COVID-19 vaccine manufacturers on today

Rediff.com20 Apr 2021

During the meeting, scheduled to be held through video conference at 6 pm on Tuesday, the Department of Biotechnology will make a presentation and also coordinate with all the participants, sources added.

FAQ: Is it safe to take antibody cocktail for Covid-19?

FAQ: Is it safe to take antibody cocktail for Covid-19?

Rediff.com10 Jun 2021

According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a patient.

Human clinical trials for COVID-19 vaccine initiated in India: ICMR

Human clinical trials for COVID-19 vaccine initiated in India: ICMR

Rediff.com14 Jul 2020

Since India is one of the largest vaccine producers in the world, it is the country's 'moral responsibility' to fast-track vaccine development process to break the chain of coronavirus transmission, ICMR Director General Dr Balram Bhargava said referring to the two vaccine candidates developed indigenously.

Serum Institute seeks DCGI nod for Covovax

Serum Institute seeks DCGI nod for Covovax

Rediff.com29 Oct 2021

There were no safety concerns arising from the study data and Covovax is safe and immunogenic in the adult population, Prakash Kumar Singh, Director, Government and Regulatory Affairs at the Serum Institute of India (SII), is learnt to have said in the application sent to the DCGI.

'There aren't many takers for Khalistan now'

'There aren't many takers for Khalistan now'

Rediff.com3 Mar 2023

'Many times when Khalistan slogans are raised, it is from those who feel alienated, not because they want a separate state.'

106 deaths in Delhi in January due to cold, claims NGO; govt denies

106 deaths in Delhi in January due to cold, claims NGO; govt denies

Rediff.com23 Jan 2022

According to a report prepared by the NGO, 106 people have died due to cold in Delhi between January 1 and January 19.

Ayurveda doctor joins race for COVID-19 cure

Ayurveda doctor joins race for COVID-19 cure

Rediff.com8 May 2020

'If the trial succeeds, it will become the success of Ayurveda.' 'If it's a failure, it's my failure alone.'

Nawab Malik's Daughter Speaks Out!

Nawab Malik's Daughter Speaks Out!

Rediff.com28 Mar 2022

'Once you are in their system, they finish you with the never-ending processes.' 'Once your family member is arrested, you are just running between lawyers, courts and the jail.' 'The process to prove that you are innocent drains you to such an extent that you are finished.'

Can This Babu Be Punjab's Giant Killer?

Can This Babu Be Punjab's Giant Killer?

Rediff.com28 Feb 2022

'The honourable prime minister virtually handpicked me for the Amritsar East seat.' 'Amit Shahji announced that if I am elected, the whole of Punjab will be drugs free.'

MP: Minor boy receives COVID-19 shot, falls sick

MP: Minor boy receives COVID-19 shot, falls sick

Rediff.com29 Aug 2021

A senior health official said the probe will find out how the teenager was given the shot even though the government is yet to roll out any anti-COVID 19 vaccination programme for minors.

Kodiyeri Balakrishnan steps aside as CPI-M secy days after son's arrest

Kodiyeri Balakrishnan steps aside as CPI-M secy days after son's arrest

Rediff.com13 Nov 2020

While the CPI-M in a statement after the secretariat on Friday maintained that Balakrishnan, who is also a Polit Bureau member, had sought leave for further treatment which had been accepted, the leader of opposition in the state assembly Ramesh Chennithala dubbed the move as a delayed dawning of wisdom.

How Biocon plans to fight COVID-19

How Biocon plans to fight COVID-19

Rediff.com4 Aug 2020

'I cannot cope with the demand. It will take us a couple of months to ramp up production.'